UBS Group AG - NEUROPACE INC ownership

NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 33 filers reported holding NEUROPACE INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.8%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NEUROPACE INC
ValueSharesWeighting
Q3 2023$535
-95.6%
55
-97.9%
0.00%
Q1 2023$12,171
+426.4%
2,623
+69.0%
0.00%
Q4 2022$2,312
-71.1%
1,552
-28.6%
0.00%
Q3 2022$8,000
+700.0%
2,173
+2051.5%
0.00%
Q1 2022$1,000
-97.4%
101
-97.3%
0.00%
Q4 2021$38,000
-37.7%
3,703
+44.5%
0.00%
Q2 2021$61,0002,5630.00%
Other shareholders
NEUROPACE INC shareholders Q2 2022
NameSharesValueWeighting ↓
Soleus Capital Management, L.P. 1,670,136$26,472,0004.12%
Orbimed Advisors 4,012,281$63,595,0000.70%
SECTORAL ASSET MANAGEMENT INC 444,572$7,046,0000.59%
KORNITZER CAPITAL MANAGEMENT INC /KS 453,012$7,180,0000.11%
Bellevue Group AG 507,930$8,051,0000.08%
JOHNSON & JOHNSON 55,435$879,0000.08%
Nantahala Capital Management 141,641$2,245,0000.07%
LORD, ABBETT & CO. LLC 359,421$5,697,0000.01%
PICTET ASSET MANAGEMENT SA 569,875$9,033,0000.01%
Ghisallo Capital Management LLC 15,000$238,0000.01%
View complete list of NEUROPACE INC shareholders